31 May - 01 June 2013 , Athens, Greece

Course Objectives

The course will present hot topics for physicians treating critically ill patients. The content will be organised roughly as hot topics in prevention, PK/PDs, treatment and developments on sepsis.

Attention: Course venue has changed!

New Course Venue

National School of Public Health
Alexandras Avenue 196
11521 Athens, Greece
www.nsph.gr

Target Audience

40 – 80 infectious disease physicians, intensivists, pulmonologists, clinical microbiologists and critical care nurses.

Dr Garyphallia Poulakou
Attikon University General Hospital
1 Rimini st
Athens, Greece

Phone +30 21058 31990
Garyphallia Poulakou

Administrative Secretariat

Imagine Congress and Travel
9 Kolokotroni st 10562
Athens, Greece

Phone +30 21032 52520
Fax +30 21032 52530

Ms Vana Antonopoulou
Vana Antonopoulou

Ms Christina Luthi
Christina Luthi

Presentations are availabe in the ESCMID Online Lecture Library.

Friday, 31 May 2013

• Welcome – Opening remarks

Prevention strategies for critically ill patients

• Surveillance cultures for vulnerable populations: lessons from the MOSAR study
• The role of SDD: when and how?
• Infection control for neutropenic patients
• Prevention of catheter-related BSIs: is zero rate feasible?
• Coffee break

Hot topics on critically ill patients

• Innovation and research in VAP and tracheobronchitis: what does the future hold?
• Linezolid or vancomycin in the treatment of MRSA pneumonia: still existing dilemmas?
• Pre-emptive vs. empirical approach in Candida infections
• Lunch

PK/PD issues for the treatment of critically ill patients

• Basic concepts of PK/PD and pharmacokinetic variations in the critically ill patient
• Novel PK/PD data on the optimisation of colistin and carbapenems

Challenging infections in the ICU

• Clostridium difficile: battling the new enemy
• The real impact of aspergillosis in nonhaematological patients
• Coffee break
• An appraisal of the usefulness of guidelines in the management of severe infections

Interactive cases

• Approaching intra-abdominal sepsis
• CNS infections in neurosurgical patients
• Closing remarks of the first day

Saturday, 1 June 2013

How to improve the therapeutic approach for the critically ill patient

• Combination or monotherapy in infectionsby MDR pathogens?
• The immunocompromised critically ill patient with MDR infection
• The revival of old antibiotics in the treatment of MDR infections
• A short overview of the drug development pipeline
• Coffee break

The strategic therapeutic approaches in themanagement of infections in critically ill patients

• Any room for de-escalation strategies? When and how?
• Any room for shortening of treatment duration? Current evidence
• Antibiotic stewardship in ICU
• Interactive case (to be announced)
• Lunch

Approaching sepsis for the critically ill patient in 2012

• The severely ill patient: what “modern management” imposes after the failure of most trials on immunointervention?
• Molecular footprinting of the invading microorganism
• Molecular footprinting of the host: is it achievable?
• I believe only in suPAR
• Closing remarks

• M. Akova, Ankara, Turkey
• A. Antoniadou, Athens, Greece
• A. Armaganidis, Athens, Greece
• M. Bassetti, Udine, Italy
• M. Bauer, Jena, Germany
• J. Chastre, Paris, France
• G. L. Daikos, Athens, Greece
• G. Dimopoulos, Athens, Greece
• E. J. Giamarellos-Bourboulis, Athens, Greece
• H. Giamarellou, Athens, Greece
• I. Karaiskos, Athens, Greece
• J. Kesecioglu, Utrecht, The Netherlands
• P. Montravers, Paris, France
• J. Paiva, Porto, Portugal
• F. Pea, Udine, Italy
• D. Plachouras, Athens, Greece
• G. Poulakou, Athens, Greece
• J. Rello, Barcelona, Spain
• J. Rodríguez-Baño, Seville, Spain
• J. F. Timsit, Grenoble, France
• D. Vogelaers, Gent, Belgium